Erlipress 1 MG Injection 10 ML is a medicine used in hospital settings to manage acute bleeding from dilated veins in the lower oesophagus (bleeding oesophageal varices), a serious complication often linked to long-term liver disease such as cirrhosis. It helps reduce blood flow to these veins, which can stop life-threatening bleeding and give the medical team time to start further treatment.
Erlipress 1 MG Injection 10 ML contains terlipressin, a vasopressin analogue. It is given intravenously by a healthcare professional, with the dose and frequency adjusted to your condition, weight, and response. It is generally used in emergency or short-term situations under specialist supervision.
This medicine is given under close monitoring in a hospital setting. Vital signs such as heart rate, blood pressure, urine output, and signs of poor circulation in the hands and feet are checked regularly during treatment. Any new chest pain, breathing difficulty, severe stomach pain, or coldness in the limbs should be reported to the healthcare team immediately.
Before receiving this medicine, the healthcare team will review your medical history, including any heart problems, uncontrolled high blood pressure, asthma, kidney problems, or other medicines you are taking. Pregnant women should generally avoid this medicine; inform the team if you are or may be pregnant.





























